{"ticker": {"uuid": "720f3f0b-9214-4f5e-91bc-de27dacfcd79", "symbol": "1650", "name": "Hygieia Group Limited", "exchange": "HKG", "country": "HK", "sector": "Industrials", "industry": "Specialty Business Services"}, "articles": [{"title": "FIDELITY FUNDS has increased its stake in Hygieia Healthcare (06078.HK) by 396,200 ordinary shares, valued at approximately HK$3.9974 million.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPN01yVVpMTDgwODVDbEU5Q2Nwdkh1ZTdpY0hnRXR4aFJjN0Jyc2xOS1JtQlB6MTNFX3hqNHRMcUIzOW5VZl82M0YxWktJOXN3ZjVJc19ISXFrUEdjdW5UQTB3VVhNQUhnNV9XaGRZNUlnT2tjVWE5WUVzS2l0UVRmTGljdHdXZEFxRFdQT1RESXdValZlY1lsUG5uNmUzbHQyNGRiTHA0b3FwWDQ?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-17T11:44:18+00:00", "published_display": "17 Jul 2026 11:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sino Biopharmaceutical buys drugmaker Hangzhou Hygieia Biomedical for up to $172 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPMmRrVExnbUdlUjBqOXZxRDlaam5HMldaY1RyUmFxd0pmSUtTZHJyMlpLX3I2M1BlbGw3bWN6MEVBdlE0Qmk0clBMUHRKank4blRsaWo3YVRleWs0WG05cWJ6cThyVkZGUVBEd3YyYTgyTVlZaHNmUXpGaWJVS2hBdDRrazA1VTlnTjZuOHY0NE1IM0ZDWDNGeVJCSm9pWmo0WnBUZElEYmVlcnJMa2k3aXQxaTJxbXBSQmJFTlpLbDJoTmpvTmU4ZUJGd0w5UFZUanM2SXVJOFZFWDNsQzgtNjlvYTdybVk?oc=5", "source_name": "Reuters", "published_at": "2026-01-13T08:00:00+00:00", "published_display": "13 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Exchange\u2019s Disciplinary Action against Hygieia Group Limited (Stock Code: 1650) and Three Directors", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOaUJyOHZOU1pBelAzQUx5OWhXR0I1Qm92ZDZRMVRZMHozdEJJY04zX013N3JaQkdjN2tONkRFX2ZsMWRKallmalNUNGxEak4xMjg5eXdSQi1FalpvRGVoOFduQjVZSTFFMXBRaUVyVl9DeV9PZmZoS1hVakhGWFEyYUZRZklkTWs?oc=5", "source_name": "hkex.com.hk", "published_at": "2023-02-28T08:00:00+00:00", "published_display": "28 Feb 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "FIDELITY FUNDS has increased its stake in Hygieia Healthcare (06078.HK) by 396,200 ordinary shares, valued at approximately HK$3.9974 million.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPN01yVVpMTDgwODVDbEU5Q2Nwdkh1ZTdpY0hnRXR4aFJjN0Jyc2xOS1JtQlB6MTNFX3hqNHRMcUIzOW5VZl82M0YxWktJOXN3ZjVJc19ISXFrUEdjdW5UQTB3VVhNQUhnNV9XaGRZNUlnT2tjVWE5WUVzS2l0UVRmTGljdHdXZEFxRFdQT1RESXdValZlY1lsUG5uNmUzbHQyNGRiTHA0b3FwWDQ?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-17T11:44:18+00:00", "published_display": "17 Jul 2026 11:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sino Biopharmaceutical buys drugmaker Hangzhou Hygieia Biomedical for up to $172 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPMmRrVExnbUdlUjBqOXZxRDlaam5HMldaY1RyUmFxd0pmSUtTZHJyMlpLX3I2M1BlbGw3bWN6MEVBdlE0Qmk0clBMUHRKank4blRsaWo3YVRleWs0WG05cWJ6cThyVkZGUVBEd3YyYTgyTVlZaHNmUXpGaWJVS2hBdDRrazA1VTlnTjZuOHY0NE1IM0ZDWDNGeVJCSm9pWmo0WnBUZElEYmVlcnJMa2k3aXQxaTJxbXBSQmJFTlpLbDJoTmpvTmU4ZUJGd0w5UFZUanM2SXVJOFZFWDNsQzgtNjlvYTdybVk?oc=5", "source_name": "Reuters", "published_at": "2026-01-13T08:00:00+00:00", "published_display": "13 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Exchange\u2019s Disciplinary Action against Hygieia Group Limited (Stock Code: 1650) and Three Directors", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOaUJyOHZOU1pBelAzQUx5OWhXR0I1Qm92ZDZRMVRZMHozdEJJY04zX013N3JaQkdjN2tONkRFX2ZsMWRKallmalNUNGxEak4xMjg5eXdSQi1FalpvRGVoOFduQjVZSTFFMXBRaUVyVl9DeV9PZmZoS1hVakhGWFEyYUZRZklkTWs?oc=5", "source_name": "hkex.com.hk", "published_at": "2023-02-28T08:00:00+00:00", "published_display": "28 Feb 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 73, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 3, "score": 50, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 68, "events": [{"event": "general", "label": "Market update", "weight": 1.45, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.14, "latest_week": "2026-07-10", "one_week_move": 2.9, "four_week_move": -0.7, "twelve_week_move": -1.9, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.060797, "market_dynamics_buy_signal": false, "relative_strength": 35.61268, "fair_value_gap": 71.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 44.1505, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.9% over one week, -0.7% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 54, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "\u5bcc\u9014\u725b\u725b", "count": 1}, {"label": "Reuters", "count": 1}, {"label": "hkex.com.hk", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 2}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "68/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+2.9% over one week, -0.7% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "FIDELITY FUNDS has increased its stake in Hygieia Healthcare (06078.HK) by 396,200 ordinary shares, valued at approximately HK$3.9974 million."}], "updated_at": "2026-07-18T09:22:15.389657+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}